<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
  <journal-id journal-id-type="publisher-id">58</journal-id>
  <journal-id journal-id-type="short-title">gdddr</journal-id>
  <journal-id journal-id-type="doi">10.31703/gdddr</journal-id>
  <journal-title-group>
    <journal-title>Global Drug Design &amp; Development Review</journal-title>
    <abbrev-journal-title abbrev-type="publisher">gdddr</abbrev-journal-title>
  </journal-title-group>
  <issn publication-format="print">2788-497X</issn>
  <issn publication-format="electronic">2788-4120</issn>
  <self-uri xlink:href="https://gdddrjournal.com"/>
  <publisher>
    <publisher-name>Humanity Publications</publisher-name>
    <publisher-loc>Pakistan</publisher-loc>
  </publisher>
</journal-meta>
<article-meta>
  <article-id pub-id-type="publisher-id">394700</article-id>
  <article-id pub-id-type="doi">10.31703/gdddr.2023(VIII-II).09</article-id>
  <article-id pub-id-type="other" specific-use="submission-id">5167</article-id>
  <article-version article-version-type="publisher">1.0</article-version>
  <article-categories>
    <subj-group subj-group-type="heading">
      <subject>article</subject>
    </subj-group>
  </article-categories>
  <title-group>
    <article-title xml:lang="en">Efficacy of Ultrasoundâ€Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan</article-title>
  </title-group>
<contrib-group>
  <contrib contrib-type="author" seq="1" corresp="yes">
    <name>
      <surname>Hussain</surname>
      <given-names>Khalid</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
    <xref ref-type="aff" rid="aff1"/>
    <xref ref-type="corresp" rid="cor1"/>
  </contrib>
  <contrib contrib-type="author" seq="2">
    <name>
      <surname>Khan</surname>
      <given-names>Attiq Ur Rehman</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff2"/>
  </contrib>
  <contrib contrib-type="author" seq="3">
    <name>
      <surname>Qureshi</surname>
      <given-names>Salman Athar</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff3"/>
  </contrib>
  <contrib contrib-type="author" seq="4">
    <name>
      <surname>Tariq</surname>
      <given-names>Ali Umair</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff4"/>
  </contrib>
  <contrib contrib-type="author" seq="5">
    <name>
      <surname>Tariq</surname>
      <given-names>Maria</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff5"/>
  </contrib>
  <contrib contrib-type="author" seq="6">
    <name>
      <surname>Ahmed</surname>
      <given-names>Bilal</given-names>
    </name>
    <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
    <xref ref-type="aff" rid="aff5"/>
  </contrib>
  <aff id="aff1">
    <label>1</label>
    <institution-wrap>
      <institution>&amp; Head, Department of Urology, GMC /Gujranwala Teaching Hospital, Gujranwala</institution>
    </institution-wrap>
    <named-content content-type="author-role">Assistant Professor</named-content>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff2">
    <label>2</label>
    <institution-wrap>
      <institution>Department of Urology, GMC/ Gujranwala Teaching Hospital, Gujranwala</institution>
    </institution-wrap>
    <named-content content-type="author-role">Assistant Professor</named-content>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff3">
    <label>3</label>
    <institution-wrap>
      <institution>Department of Anesthesia, GMC/ Gujranwala Teaching Hospital, Gujranwala</institution>
    </institution-wrap>
    <named-content content-type="author-role">Associate Professor</named-content>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff4">
    <label>4</label>
    <institution-wrap>
      <institution>MBBS, Gujranwala Medical College, Gujranwala</institution>
    </institution-wrap>
    <named-content content-type="author-role">Student</named-content>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
  <aff id="aff5">
    <label>5</label>
    <institution-wrap>
      <institution>PGR, Department of Urology, GMC/ Gujranwala Teaching Hospital, Gujranwala</institution>
    </institution-wrap>
    <addr-line>Punjab</addr-line>
    <country>Pakistan</country>
  </aff>
</contrib-group>
<author-notes>
  <corresp id="cor1">Corresponding Author: Khalid Hussain, Assistant Professor &amp; Head, Department of Urology, GMC /Gujranwala Teaching Hospital, Gujranwala, Punjab, Pakistan.</corresp>
<fn fn-type="COI-statement" id="fn-coi">
  <p>The authors declare that they have no conflicts of interest.</p>
</fn>
<fn fn-type="ethics-statement" id="fn-ethics">
  <p>This study did not require formal ethics approval.</p>
</fn>
<fn fn-type="data-availability-statement" id="fn-data">
  <p>Data sharing is not applicable to this article.</p>
</fn>
</author-notes>
<pub-date pub-type="epub" date-type="pub" publication-format="electronic">
  <day>30</day>
  <month>06</month>
  <year>2023</year>
</pub-date>
<pub-date pub-type="collection">
  <month>06</month>
  <year>2023</year>
</pub-date>
<pub-date date-type="pub" publication-format="print">
  <day>22</day>
  <month>05</month>
  <year>2023</year>
</pub-date>
  <volume>8</volume>
  <issue>2</issue>
  <season>Spring</season>
  <fpage>69</fpage>
  <lpage>73</lpage>
  <history>
    <date date-type="accepted">
      <day>22</day>
      <month>05</month>
      <year>2023</year>
    </date>
  </history>
<funding-group>
  <funding-statement>
<p>The authors received no specific funding for this work.</p>
  </funding-statement>
</funding-group>
<permissions>
  <copyright-year>2023</copyright-year>
  <copyright-holder>Humanity Publications</copyright-holder>
  <license license-type="open-access" xml:lang="en" xlink:href="https://creativecommons.org/licenses/by/4.0/">
    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License.</license-p>
  </license>
</permissions>
<self-uri content-type="text/html" xlink:href="https://gdddrjournal.com/article/efficacy-of-ultrasoundguided-double-lumen-central-venous-catheter-insertion-in-minimizing-mechanical-complications-and-bloodstream-infections-an-empirical-evidence-of-pakistan"/>
<self-uri content-type="pdf" xlink:href="https://gdddrjournal.com/pdf/gdddr/q5mH9JVfLb.pdf"/>
<supplementary-material id="suppl-pdf" content-type="pdf" xlink:href="https://gdddrjournal.com/pdf/gdddr/q5mH9JVfLb.pdf">
  <label>PDF</label>
  <caption>
    <title>Full Text PDF</title>
  </caption>
</supplementary-material>
  <abstract>
    <p>The aim of the study was to compare the outcomes of ultrasoundâ€guided doubleâ€lumen central venous catheter (DLC) insertion and without ultrasound guidance in reducing mechanical complications and bloodstream infections. This quasiâ€experimental study was conducted at Urology Department in collaboration with the Anesthesia department at GMC Teaching Hospital Gujranwala. The study had 60 insertions in each group. The insertion duration ranged from 8â€50 days in Group A and 9â€60 days in the B group. Placements were done at the right internal jugular and right subclavian veins. Four patients in Group A and five patients in Group B experienced catheterâ€related bloodstream infections (CRBSI), but the difference was not significant. The Charlson Comorbidity Index (CCI) was 0â€10 in Group A and 0â€8 in Group B. Group A had no mechanical complications, while three patients in Group B experienced manageable complications. In conclusion, ultrasoundâ€guided DLC placement improves safety but does not reduce CRBSI.</p>
  </abstract>
<kwd-group kwd-group-type="author-keywords">
  <kwd>Dialysis</kwd>
  <kwd>DLC</kwd>
  <kwd>Ultrasound</kwd>
</kwd-group>
  <custom-meta-group>
    <custom-meta><meta-name>views</meta-name><meta-value>1032</meta-value></custom-meta>
    <custom-meta><meta-name>downloads</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>html-views</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>google-scholar-citations</meta-name><meta-value>0</meta-value></custom-meta>
    <custom-meta><meta-name>crossref-citations</meta-name><meta-value>0</meta-value></custom-meta>
  </custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec-1">
  <title>Introduction</title>
<p>For patients who require vascular access for hemodialysis and severe critical care, double-lumen central venous catheters (DLC) are an effective therapy option. A DLC enables vascular access for hemodialysis and parenteral nutrition supplementation. The use of DLC  is associated with many adverse events, such as deep venous thrombosis, intravenous catheter-associated infections and mechanical complications, even though they allow for the delivery of nutritional support and for the vascular access needed for hemodialysis that is difficult and unsafe to place via a peripheral vein (Machat et al., 2019). To overcome these complications Healthcare Infection Control Practices Advisory Committee has established guidelines for prevention of the intravascular catheter-related infection: aseptic technique, hand hygiene, catheter site dressing regimens, skin decontamination, and maximal barrier precautions. However, there is limited data about whether USG-guided DLC placement reduces the chances of CRBSI and infections. (Imataki et al., 2019).</p>
</sec>
<sec id="sec-2">
  <title>Methods</title>
<p>This quasi-experimental study, which included 120 patients, (60 in each group) underwent DLC needed for hemodialysis and parental nutrition at the Department of Urology in collaboration with the Department of Anesthesia between January 2022 and December 2022. Group A patients underwent USG-guided DLC placement while in Group B DLC placement was done without USG guidance. Patients with haematological or immunological illnesses who needed parental nutrition and patient with CKD-V or AKI who needed DLC placement for dialysis were included in our study.</p><p><break/></p><p>Treatment regimens</p><p>In this study, the Arrow double lumen (7Fr; Arrow) catheter was used. The hospital training programme that taught the standard insertion method was attended by all of the practitioners who took part in this study. Each practitioner decided about the indication of placement of DLC was necessary, as well as the best DLC catheter and the site for DLC insertion for every patient. Maximal sterile measures were adopted. The skin was prepped with a 10% tincture of povidone-iodine, and the catheter site was regularly dressed with Tegaderm Transparent Film Dressing.</p><p><break/></p><p><break/></p><p>Definition</p><p>Positive blood culture was used to define bloodstream infections (BSI) (Ombelet et al., 2019). The blood culture data were extensively examined by more than two investigators to differentiate between a real BSI and contamination. Additionally, a CRBSI was defined as the presence of bacteremia originating from an intravenous catheter with positive blood culture for the same organism on both peripheral smear and catheter tip. The possibility of other infection sources was clinically assessed. For the CRBSI diagnosis, HICPAC recommendation criteria are used (Buetti et al., 2022). Hematoma, arterial puncture and pneumothorax are mechanical complications.</p><p>Grade I bleeding involves minor symptoms, grade II bleeding necessitates medical intervention, grade III bleeding necessitates radiologic, endoscopic, transfusion, or surgery, while life-threatening hemodynamic or respiratory compromise comes from grade IV haemorrhage. Grade I pneumothoraxes are asymptomatic, Grade II pneumothoraxes are symptomatic, Grade III pneumothoraxes are indicative of sclerosis and/or surgical intervention, and Grade IV are potentially fatal. Garde I hematomas have modest symptoms, grade II hematomas are advised for minimally invasive evacuation or aspiration, and grade III hematomas are indicated for elective surgical intervention, radiologic, or endoscopic. While hematomas of grade IV are fatal. A widespread and effective measure for assessing general problems, organ dysfunction, and comorbidities is the Charlson comorbidity index. (Charlson et al., 2022). The study&apos;s major aim was to determine how the frequency of CRBSI was impacted by ultrasound guidance during CVC insertion.</p><p><break/></p><p>Statistical Analysis</p><p>Data was entered in SPSS version 22.0 before statistical analysis. The quantitative variables were presented as mean (±standard deviation). An Independent sample t-test was used for the comparison of quantitative variables when appropriate.  For all tests, a p-value less than 0.05 was regarded as significant. The multivariate analytic method was employed to investigate the risk factors for catheter-related infections. In the multivariate analysis, we used the regression model to assess the patient&apos;s biodata like gender, age and other clinical parameters and other conditions related to the catheter like duration, site and CRBSI onset as a dependent variable. The background risk factors mentioned above and a stepwise selection technique were used to build the multivariable logistic regression model.</p>
</sec>
<sec id="sec-3">
  <title>Results</title>
<p>A total of 120 (60 in
each group) insertion cases were done during our study at the Department of
Urology in collaboration with Department of Anesthesia, GMC Teaching Hospital, Gujranwala.
Patients with haematological or immunological illnesses who needed parental
nutrition and patient with CKD-V or AKI who needed DLC placement for dialysis
were included in our study. The age of patients in Group A ranged from 18-50
years while in Group B ranged from 19-60. 32 patients in Group A were males and
40 patients were males in Group B. The duration of insertion ranged from 8-50
days in Group A and 9-60 days in Group B. In group A 57 DLC placements were
done in the right internal jugular vein while 03 insertions were performed at
the right subclavian veins. In group B 50 DLC placements were done in the right
internal jugular vein while 10 insertions were performed at the right
subclavian vein. A total of 04 patients in Group A and 05 patients in Group B
had CRBSI. Results were not significant regarding CRBSI. Gram-negative bacilli,
gram-positive bacilli, and gram-positive cocci were the main bacteria causing
CRBSI, but the results were not different regarding CRBSI between both groups.  The Charlson Comorbidity Index (CCI) in our
study was 0-10 in Group A and 0-8 in Group B. In group A no patients had any
mechanical complications while in group B 03 patients had mechanical
complications but all patients management conservatively. 02 cases of grade II
pneumothorax were observed and grade I bleeding with grade II hematoma was
observed in only one patient.</p> <p><break/></p><p><bold>Table 1</bold></p><table-wrap id="table1"><label>Table 1</label><caption><title>Table 1</title></caption><table><tbody><tr><td> <p><bold>Variables </bold></p> </td><td colspan="3"> <p><bold>Group A (USG
  Guided)</bold></p> </td><td colspan="2"> <p><bold>Group B
  (Non-USG)</bold></p> </td></tr><tr><td> <p>Number</p> </td><td colspan="3"> <p>60</p> </td><td colspan="2"> <p>60</p> </td></tr><tr><td rowspan="2"> <p>Gender</p> </td><td> <p><bold>Male</bold></p> </td><td colspan="2"> <p><bold>Female</bold></p> </td><td> <p><bold>Male</bold></p> </td><td> <p><bold>Female</bold></p> </td></tr><tr><td> <p>32</p> </td><td colspan="2"> <p>28</p> </td><td> <p>40</p> </td><td> <p>20</p> </td></tr><tr><td> <p>Age</p> </td><td colspan="3"> <p>18-50 years</p> </td><td colspan="2"> <p>19-60 years</p> </td></tr><tr><td> <p>CCI</p> </td><td colspan="3"> <p>0-10 score</p> </td><td colspan="2"> <p>0-8 score</p> </td></tr><tr><td rowspan="2"> <p>Site</p> </td><td colspan="2"> <p><bold>Right Internal Jugular vein</bold></p> </td><td> <p><bold>Right Subclavian vein</bold></p> </td><td> <p><bold>Right Internal Jugular vein</bold></p> </td><td> <p><bold>Right Subclavian vein</bold></p> </td></tr><tr><td colspan="2"> <p>57</p> </td><td> <p>03</p> </td><td> <p>50</p> </td><td> <p>10</p> </td></tr><tr><td> <p>Duration
  of catheter</p> </td><td colspan="3"> <p>8-50 days</p> </td><td colspan="2"> <p>9-60 days</p> </td></tr><tr><td> <p>CRBSI</p> </td><td colspan="3"> <p>04</p> </td><td colspan="2"> <p>05</p> </td></tr><tr><td> <p>Mechanical
  Complications</p> </td><td colspan="3"> <p>00</p> </td><td colspan="2"> <p>03</p> </td></tr></tbody></table></table-wrap>
</sec>
<sec id="sec-4">
  <title>Discussion</title>
<p>Our study demonstrates that employing DLC placement with the help of ultrasound guidance does not significantly lower the risk of catheter-related bloodstream infections. Our research findings are close to those of an earlier study, which showed CRBSI of 24.5% in cases of haematological malignancies that included stem cell transplant recipients (Lukenbill et al., 2013). The DLC insertion location and line usage length were time-related factors in this study. The following is a list of the further developments discovered concurrently with the use of the USG-guided technique in our quasi-experimental study:  (1) More DLC is being placed in the internal jugular vein. (2) Decrease in the number of DLC insertions into subclavian veins, which is a major drop from the subclavian vein approach. (3) Increasing in number of catheter placements on the right side. All of these purposeful actions at our department were done to lessen the DLC-related issues in our hospital and by adapting these approaches in CKD-V patients we can save the left non-dominant hand for future arteriovenous fistula in most of patients. Although catheter-related bloodstream infections did not become less common over the research period. In contrast, with the development of the ultrasound-guided DLC insertion technique, mechanical complications drastically decreased. The in-house preferred suggestions that resulted from the trend of DLC insertion techniques for increasing the safety of patients described in our research are (1) a right internal jugular vein approach employing a double lumen, (2) a shorter insertion duration and early catheter removal. These suggestions, in our opinion, are necessary to avoid a variety of negative hazards, including BSI. Compared to the landmark approach, CVC placement using ultrasound guidance is a safer operation. (Saugel et al., 2017). Previous research has revealed that cannulation using ultrasound has other positive effects, such as a higher success rate for catheterization. (Maecken et al., 2015) In one trial, the authors claimed that ultrasound guiding had a success rate of 100 per cent (Karimi-Sari et al., 2014). Additional documented advantages include decreased complications such as hematomas, carotid punctures, hemothoraxes, and pneumothoraxes as well as shorter mean access times and mean attempt numbers (Xia et al., 2018). Additionally, the mechanical complications—pneumothorax, hematoma, and thoracic bleeding—showed a remarkable decrease in our research sample. Any location can be used for ultrasound-guided cannulation, including the internal jugular vein, subclavian vein, brachiocephalic vein, and others. Patients of any age can have this procedure (Van Gent et al., 2017). Our survey showed an intervention that led to a general change in the management of DLC insertion to reduce the risks causing mechanical complications, which are major DLC-related adverse events, whether they are intentional or unintentional (pneumothorax and hematoma or other organ injuries). Any provider&apos;s ability to employ ultrasound technology must be improved via training. However, we found no evidence of a delay in the impact of ultrasonography guiding. The safety of DLC implantation quickly and significantly increased thanks to the ultrasonic approach. However, despite the advent of ultrasound-guided DLC insertion, the risk of catheter-related bloodstream infections remained the same. Our quasi-experimental study&apos;s non-randomized constituted a significant flaw. The significant variations in the patients&apos; background characteristics were another important limitation drawback of our study. Finally, only professionals who have received thorough training in this approach should use ultrasound guidance.</p>
</sec>
<sec id="sec-5">
  <title>Conclusion</title>
<p>Our study shows that despite the use of ultrasound for DLC insertion there is no reduction in catheter-related bloodstream infections but the use of USG-guided DLC placement overall improves the safety of the patient for placing catheter with or without the intent of the physician.</p>
</sec>
</body>
<back>
<fn-group content-type="conflict-of-interest">
  <title>Conflict of Interest</title>
  <fn fn-type="conflict">
<p>The authors declare that they have no conflicts of interest.</p>
  </fn>
</fn-group>
<fn-group content-type="ethics-statement">
  <title>Ethics Statement</title>
  <fn fn-type="ethics">
<p>This study did not require formal ethics approval.</p>
  </fn>
</fn-group>
<fn-group content-type="data-availability">
  <title>Data Availability</title>
  <fn fn-type="data-availability-statement">
<p>Data sharing is not applicable to this article.</p>
  </fn>
</fn-group>
<app-group>
  <app id="app-suppl">
    <title>Supplementary Materials</title>
<supplementary-material id="suppl-pdf" content-type="pdf" xlink:href="https://gdddrjournal.com/pdf/gdddr/q5mH9JVfLb.pdf">
  <label>PDF</label>
  <caption>
    <title>Full Text PDF</title>
  </caption>
</supplementary-material>
  </app>
</app-group>
<ref-list>
  <title>References</title>
<ref id="Amsterdam">
  <label>1</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Amsterdam, J. D., &amp; Shults, J</person-group>
    <year>2009</year>
    <source>Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? Journal of Affective Disorders</source>
    <page-range>atients</page-range>
    Amsterdam, J. D., &amp; Shults, J. (2009). Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? Journal of Affective Disorders, 115(1-2), 234â€“240.
    <pub-id pub-id-type="doi">10.1016/j.jad.2008.07.007</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/j.jad.2008.07.007">10.1016/j.jad.2008.07.007</ext-link>
  </mixed-citation>
</ref>
<ref id="Buchborn">
  <label>3</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Buchborn, T., Lyons, T., &amp; KnÃ¶pfel, T</person-group>
    <year>2018</year>
    <article-title>. Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice</article-title>
    <source>Frontiers in Pharmacology, 9</source>
    <page-range>fel</page-range>
    Buchborn, T., Lyons, T., &amp; KnÃ¶pfel, T. (2018). Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice. Frontiers in Pharmacology, 9.
    <pub-id pub-id-type="doi">10.3389/fphar.2018.00017</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.3389/fphar.2018.00017">10.3389/fphar.2018.00017</ext-link>
  </mixed-citation>
</ref>
<ref id="Darmani">
  <label>4</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Darmani, N. A., &amp; Gerdes, C. F</person-group>
    <year>1995</year>
    <article-title>. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI</article-title>
    <source>Pharmacology Biochemistry and Behavior</source>
    <volume>50</volume>
    <issue>4</issue>
    <fpage>545</fpage>
    Darmani, N. A., &amp; Gerdes, C. F. (1995). Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacology Biochemistry and Behavior, 50(4), 545â€“550.
    <pub-id pub-id-type="doi">10.1016/0091-3057(94)00340-8</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/0091-3057(94)00340-8">10.1016/0091-3057(94)00340-8</ext-link>
  </mixed-citation>
</ref>
<ref id="Goto">
  <label>5</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Goto, S., Terao, T., Tomita, M., &amp; Uchimura, N</person-group>
    <year>2012</year>
    <article-title>. Aripiprazole may be free from tachyphylaxis: Preliminary findings</article-title>
    <source>Psychiatry and Clinical Neurosciences</source>
    <volume>66</volume>
    <issue>2</issue>
    <fpage>160</fpage>
    Goto, S., Terao, T., Tomita, M., &amp; Uchimura, N. (2012). Aripiprazole may be free from tachyphylaxis: Preliminary findings. Psychiatry and Clinical Neurosciences, 66(2), 160â€“162.
    <pub-id pub-id-type="doi">10.1111/j.1440-1819.2011.02301.x</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1111/j.1440-1819.2011.02301.x">10.1111/j.1440-1819.2011.02301.x</ext-link>
  </mixed-citation>
</ref>
<ref id="Kinrys">
  <label>6</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., &amp; Fava, M</person-group>
    <year>2019</year>
    <article-title>. Tachyphylaxis in major depressive disorder: A review of the current state of research</article-title>
    <source>Journal of Affective Disorders</source>
    <page-range>isano</page-range>
    Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., &amp; Fava, M. (2019). Tachyphylaxis in major depressive disorder: A review of the current state of research. Journal of Affective Disorders, 245, 488â€“497.
    <pub-id pub-id-type="doi">10.1016/j.jad.2018.10.357</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/j.jad.2018.10.357">10.1016/j.jad.2018.10.357</ext-link>
  </mixed-citation>
</ref>
<ref id="Katz">
  <label>7</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Katz, G</person-group>
    <year>2011</year>
    <article-title>. Tachyphylaxis/ tolerance to antidepressive medications: a review</article-title>
    <source>The Israel Journal of Psychiatry and Related Sciences</source>
    <volume>48</volume>
    <issue>2</issue>
    <fpage>129</fpage>
    Katz, G. (2011). Tachyphylaxis/ tolerance to antidepressive medications: a review. The Israel Journal of Psychiatry and Related Sciences, 48(2), 129â€“135.
    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22120449/">https://pubmed.ncbi.nlm.nih.gov/22120449/</ext-link>
  </mixed-citation>
</ref>
<ref id="Lieb">
  <label>8</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Lieb, J., &amp; Balter, A</person-group>
    <year>1984</year>
    <article-title>. Antidepressant tachyphylaxis</article-title>
    <source>Medical Hypotheses</source>
    <volume>15</volume>
    <issue>3</issue>
    <fpage>279</fpage>
    Lieb, J., &amp; Balter, A. (1984). Antidepressant tachyphylaxis . Medical Hypotheses, 15(3), 279â€“291.
    <pub-id pub-id-type="doi">10.1016/0306-9877(84)90018-5</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/0306-9877(84)90018-5">10.1016/0306-9877(84)90018-5</ext-link>
  </mixed-citation>
</ref>
<ref id="Pietrzykowski">
  <label>9</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Pietrzykowski, A. Z., &amp; Treistman, S. N</person-group>
    <year>2008</year>
    <article-title>. The Molecular Basis of Tolerance</article-title>
    <source>Alcohol Research &amp; Health</source>
    <volume>31</volume>
    <issue>4</issue>
    <fpage>298</fpage>
    Pietrzykowski, A. Z., &amp; Treistman, S. N. (2008). The Molecular Basis of Tolerance. Alcohol Research &amp; Health, 31(4), 298â€“309.
    <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860466/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860466/</ext-link>
  </mixed-citation>
</ref>
<ref id="Rothschild">
  <label>10</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Rothschild, A. J</person-group>
    <year>2008</year>
    <article-title>. The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity</article-title>
    <source>Comprehensive Psychiatry</source>
    <volume>49</volume>
    <issue>5</issue>
    <fpage>508</fpage>
    Rothschild, A. J. (2008). The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity . Comprehensive Psychiatry, 49(5), 508â€“513.
    <pub-id pub-id-type="doi">10.1016/j.comppsych.2008.03.002</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/j.comppsych.2008.03.002">10.1016/j.comppsych.2008.03.002</ext-link>
  </mixed-citation>
</ref>
<ref id="Skaff">
  <label>11</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Skaff, R</person-group>
    <year>2019</year>
    <article-title>. Tachyphylaxis and desensitization depression</article-title>
    <source>CNS Spectrums, 1â€“2</source>
    Skaff, R. (2019). Tachyphylaxis and desensitization depression . CNS Spectrums, 1â€“2.
    <pub-id pub-id-type="doi">10.1017/s1092852919001445</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1017/s1092852919001445">10.1017/s1092852919001445</ext-link>
  </mixed-citation>
</ref>
<ref id="Sj">
  <label>12</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">SjÃ¶stedt, P., Enander, J., &amp; Isung, J</person-group>
    <year>2021</year>
    <article-title>. Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis</article-title>
    <source>Frontiers in Psychiatry, 12</source>
    <page-range>sychiatry</page-range>
    SjÃ¶stedt, P., Enander, J., &amp; Isung, J. (2021). Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis. Frontiers in Psychiatry, 12.
    <pub-id pub-id-type="doi">10.3389/fpsyt.2021.682868</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.3389/fpsyt.2021.682868">10.3389/fpsyt.2021.682868</ext-link>
  </mixed-citation>
</ref>
<ref id="Svensson">
  <label>13</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Svensson, C. K</person-group>
    <year>2022</year>
    <article-title>. Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance</article-title>
    <source>Journal of Pharmacology and Experimental Therapeutics</source>
    <page-range>roposal</page-range>
    Svensson, C. K. (2022). Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance. Journal of Pharmacology and Experimental Therapeutics.
    <pub-id pub-id-type="doi">10.1124/jpet.121.000978</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1124/jpet.121.000978">10.1124/jpet.121.000978</ext-link>
  </mixed-citation>
</ref>
<ref id="Targum">
  <label>14</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Targum, S. D</person-group>
    <year>2014</year>
    <article-title>. Identification and treatment of antidepressant tachyphylaxis</article-title>
    <source>Innovations in Clinical Neuroscience</source>
    Targum, S. D. (2014). Identification and treatment of antidepressant tachyphylaxis. Innovations in Clinical Neuroscience, 11(3-4), 24â€“28.
    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24800130/">https://pubmed.ncbi.nlm.nih.gov/24800130/</ext-link>
  </mixed-citation>
</ref>
<ref id="Uchida">
  <label>15</label>
  <mixed-citation publication-type="journal">
    <person-group person-group-type="author">Uchida, H., &amp; Mamo, D. C</person-group>
    <year>2009</year>
    <article-title>. Dosing of antipsychotics in schizophrenia across the life-spectrum</article-title>
    <source>Progress in Neuro- Psychopharmacology &amp; Biological Psychiatry</source>
    <volume>33</volume>
    <issue>6</issue>
    <fpage>917</fpage>
    Uchida, H., &amp; Mamo, D. C. (2009). Dosing of antipsychotics in schizophrenia across the life-spectrum. Progress in Neuro- Psychopharmacology &amp; Biological Psychiatry, 33(6), 917â€“920.
    <pub-id pub-id-type="doi">10.1016/j.pnpbp.2009.04.023</pub-id>
    <ext-link ext-link-type="doi" xlink:href="https://doi.org/10.1016/j.pnpbp.2009.04.023">10.1016/j.pnpbp.2009.04.023</ext-link>
  </mixed-citation>
</ref>
</ref-list>
</back>
</article>